(Q39850215)

15 September 2017

1 reference

title

The problems and the promise of prostaglandin influences in atherogenesis (English)

1 reference

15 September 2017

Moncada S

1

1 reference

15 September 2017

Radomski MW

series ordinal

2

1 reference

15 September 2017

language of work or name

English

0 references

publication date

1 January 1985

1 reference

Annals of the New York Academy of Sciences

15 September 2017

published in

1 reference

15 September 2017

volume

454

1 reference

15 September 2017

page(s)

121-130

1 reference

Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall. An explanation for the anti-thrombotic properties of vascular endothelium

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB11850.X

Synthesis of prostaglandin I2 (prostacyclin) by cultured human and bovine endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB11850.X

Localisation and stimulation of prostacyclin production in vascular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB11850.X

An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB11850.X

Circulatory and anti-platelet effects of intravenous prostacyclin in healthy men

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB11850.X

Prevention of blockage of partially obstructed coronary arteries with prostacyclin correlates with inhibition of platelet aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB11850.X

Anti-aggregatory effect of prostacyclin (PGI2) in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB11850.X

Topical prostacyclin (PGI2) inhibits platelet aggregation in pial venules of the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB11850.X

Recirculation of prostacyclin (PGI2) in the dog

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB11850.X

Human plasma transforms prostacyclin (PGI2) into a platelet antiaggregatory substance which contracts isolated bovine coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB11850.X

The chemical structure of prostaglandin X (prostacyclin)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB11850.X

Eighth Gaddum Memorial Lecture. University of London Institute of Education, December 1980. Biological importance of prostacyclin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB11850.X

Modulation of human platelet adenylate cyclase by prostacyclin (PGX)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB11850.X

Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB11850.X

Stimulation of calcium uptake in platelet membrane vesicles by adenosine 3′,5′-cyclic monophosphate and protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB11850.X

Cyclic adenosine 3′,5′-monophosphate and prostacyclin inhibit membrane phospholipase activity in platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB11850.X

Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB11850.X

Cyclic AMP inhibits synthesis of prostaglandin endoperoxide (PGG2) in human platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB11850.X

Regulation of endothelial cell cyclic nucleotide metabolism by prostacyclin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB11850.X

Effect of prostacyclin (PGI2) on platelet adhesion to rabbit arterial subendothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB11850.X

Studies on the protective effect of prostacyclin in acute myocardial ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB11850.X

Prostacyclin in experimental myocardial ischemia: effects on hemodynamics, regional myocardial blood flow, infarct size and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB11850.X

Salutary effects of prostacyclin in endotoxic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB11850.X

Further studies on the enzymatic conversion of prostaglandin endoperoxide into prostacyclin by porcine aorta microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB11850.X

Myocardial infarction over a five-year period. I. Prevalence, incidence and mortality experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB11850.X

Plasma high-density lipoproteins and ischemic heart disease: studies in a large kindred with familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB11850.X

Lipoproteins and the inhibitory effect of human endothelial cells on platelet function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB11850.X

Influence of human low density and high density lipoprotein cholesterol on the in vitro prostaglandin I2 synthetase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB11850.X

Prostacyclin modulates cholesteryl ester hydrolytic activity by its effect on cyclic adenosine monophosphate in rabbit aortic smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB11850.X

Prostacyclin analogues as antiatherosclerotic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB11850.X

The platelet-derived growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB11850.X

Haemostatic function and platelet polyunsaturated fatty acids in Eskimos

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB11850.X

Evidence for the mechanism by which eicosapentaenoic acid inhibits human platelet aggregation and secretion - implications for the prevention of vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB11850.X

Inhibition of prostaglandin biosynthesis by eicosapentaenoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB11850.X

Triene prostaglandins: prostacyclin and thromboxane biosynthesis and unique biological properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB11850.X

Preparation and biochemical properties of PGH3

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB11850.X

Biology and therapeutic potential of prostacyclin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB11850.X

Prostacyclin production by cultured smooth muscle cells from atherosclerotic rabbit aorta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB11850.X

Prostaglandin I3 is formed in vivo in man after dietary eicosapentaenoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB11850.X

10.1111/J.1749-6632.1985.TB11850.X

21 January 2018

Identifiers

DOI

1 reference

15 September 2017

1 reference